How Red Wine Lost It's "Heart Healthy" Reputation
For 30 years, a daily glass looked heart-healthy. Then researchers found who was in the “non-drinker” group, and the story changed.
Welcome to the positive corner of the internet. We’re here to make your life healthier, happier, and less stressful. At the bottom of each email, we explain our editorial process, stance on AI, and partnership standards.
If you were forwarded this message, you can get the free daily email here.
Today’s Health Upgrade
The problem screen time might be hiding
What’s really in “mushroom coffee?”
Nutrition Q&A
Wine was “healthy”…and then it wasn’t
Deep dive: hormone therapy and breast cancer
On Our Radar
Rethinking Screen Time
Most conversations about screen time and children focus on hours spent on devices. And that matters, but it might be covering up a bigger issue.
Hours tell you less than you’d think. The better question is whether your kid feels connected to people, because loneliness and problem scrolling tend to feed each other, and a time limit doesn’t break that loop on its own.
Take the three-hour mark. In a study following more than 6,000 teens, those on social media more than three hours a day had about 60% higher odds of reporting anxiety and depression symptoms than nonusers. In the past six hours, that number jumped to 78%. Those were self-reported symptoms, not diagnoses, and the study can’t show social media caused them.
But in other studies, across roughly 355,000 teens, tech use explained at most 0.4% of differences in well-being. One of those authors had previously held unpaid advisory roles with Facebook and Google. When Jean Twenge, Jonathan Haidt and colleagues reanalyzed the same data, separating social media from everything else and looking at girls on their own, the links got stronger. Same data. Better question.
Then there’s the chicken-and-egg problem. A six-month study of 1,185 teens tracked loneliness and problematic social media use side by side.
Loneliness predicted more problematic scrolling later. Problem scrolling predicted more loneliness. It runs both ways.
So taking the phone away might end the fight. But if your kid is lonely, the loneliness is still there. Cutting back on social media does help a little, though those studies mostly tested young adults, not teens.
What seems to protect kids is feeling close to someone.
In a CDC survey of high schoolers, teens who felt connected to people at school were far less likely to report persistent sadness or hopelessness. About 1 in 3 did, compared with roughly 1 in 2 of teens who didn’t feel that connection. It’s one snapshot from a pandemic year, so it can’t prove connection is the cause. But it points to something you can influence.
That starts at home, and your phone is part of it. In families with young kids, nearly half of parents said tech interrupted time with their child at least three times a day.
So instead of just counting minutes, fix what’s going wrong. If your kid is scrolling at midnight, the real issue is sleep, so phones charge in the kitchen overnight. If one account always leaves them feeling worse, sit down together and unfollow it. Bullying or self-harm content gets dealt with right away, even if they were only on for ten minutes.
Then make room to talk. There are endless ways to make it happen: Pick one daily stretch with no devices, yours included. Dinner works. Car rides often work better, because sitting side by side feels less like an interrogation. Skip “How long were you on your phone?” and ask who they sat with at lunch, or who they’d text if something went wrong. Those answers tell you more than any screen-time report.
If sadness, withdrawal, or sleep changes stick around, call your pediatrician, even if screen time has gone down. In a crisis, you can always call or text 988.
Together with Pique
The Mushroom Coffee Problem (That Isn’t Easy To Spot)
Most people looking for a coffee alternative want the same thing: steady energy without the jitters, the crash, or the third cup by 2 p.m. Options are everywhere, and many people end up paying for something that can’t do what the bag promises.
It’s a quiet bait-and-switch, and mushroom coffee needs more clarity than anything. If you go by marketing alone, you might think it’s as simple as Lion’s Mane for focus, Cordyceps for energy, and Reishi to wind down. The names on the bag sound the same across brands. What’s inside often isn’t.
When Nammex, a mushroom supplier, lab-tested close to 100 commercial mushroom samples, many turned out to be a third or more grain starch.
A mushroom has two parts. The fruiting body is the part you’d recognize, the cap and stem, and it’s where beta-glucans, the most studied compounds, are most concentrated. Mycelium is the root-like network underneath. It’s cheaper and faster to grow, usually on rice or oats. At harvest, the grain gets ground in with it and sold under the same species name.
The numbers are hard to ignore. Whole dried reishi tested at 28.1% beta-glucan and 0.1% starch. Reishi mycelium products ranged from about 1% to 7% beta-glucan, with roughly half their weight as starch. Across all the grain-grown samples, starch averaged 35 to 40 percent.
To be fair, Nammex sells fruiting-body mushrooms, so it isn’t neutral here. And mycelium isn’t useless. Some compounds, like those in lion’s mane, are found mainly in the mycelium.
But the chemistry is simple: you may be paying mushroom prices for a lot of oat flour.
So two quick checks before you buy anything with a mushroom on the label. Does it say fruiting body? And does it list beta-glucans instead of “polysaccharides”? The polysaccharide number counts grain starch too, which makes a weak product look strong.
We used those two checks when we tested coffee alternatives. The one that kept ending up in our mugs was Pique’s Nandaka.
The Lion’s Mane and Cordyceps are 8:1 fruiting-body extracts, combined with whole fruiting-body powder, so you get the concentrated compounds and the whole mushroom. Reishi and Chaga round out the blend.
Ceremonial Peruvian cacao keeps up to 30% of its natural cocoa butter, which gives it real body. Fermented black and green Pu’er from 250-year-old tea trees brings the energy, plus a little Ayurvedic spice. It tastes rich, with dark-fruit notes, and it’s coffee-like without any coffee.
To be clear, the Pu’er has caffeine, so Nandaka isn’t caffeine-free. It’s a different kind of approach to energy and focus. The caffeine-and-theanine combo helps provide sustained energy without the jitters or crash. The Pu’er tea is also heart-healthy and associated with lower cholesterol and triglycerides.
For Black Friday, Pump Club readers get 25% off sitewide plus free Holiday-Edition Chais. Every order also comes with Pique’s 90-day money-back guarantee, so you have plenty of time to see if it sticks. The offer runs through November 29.
Most Black Friday deals are about getting more. This one’s about getting what you want for your body.
Community
LIVE Nutrition Q&A Today
Do you have a nutrition question that’s been driving you crazy? Maybe something about performance, fat loss, muscle gain, longevity, supplements, or popular diet plans?
Today at 12 pm PST/3 pm EST, join Adam Bornstein, Pump Club Co-CEO and Co-Editor-in-Chief, for a live Nutrition Q&A.
Mark your calendar with a reminder. The event is completely free. Join the call here
Health
The Non-Drinkers Who Made Wine Look Good
For about 30 years, a glass of red with dinner seemed to come with a doctor’s note of approval.
Science made it seem like a little wine was good for your heart. It turns out that recommendation was based on a bad comparison and misleading data.
The early evidence came from studies that tracked drinkers and non-drinkers for years and counted who died first. Light drinkers kept coming out ahead. That’s the famous J-curve: a little alcohol looked better than none.
However, many variables make the data less straightforward than it looks.
For example, plenty of people stop drinking because they’re already sick. A doctor told them to cut out alcohol, a medication didn’t mix, or their liver made the call for them.
Those people — who were sick, diseased, or struggling with their health — were counted as “non-drinkers,” which biased the data.
In a research review of 107 studies covering nearly 5 million people, 86 lumped former or occasional drinkers in with people who never drank.
People who quit drinking had about 26% higher death rates than people who never drank. If you count them as “non-drinkers,” the whole group looks sicker, so light drinkers look healthy by comparison. It also helped that light drinkers tended to exercise more, eat more vegetables, and smoke less.
Once researchers fixed that mix-up and a few other study flaws, the benefit mostly faded. And at higher amounts, risk went up.
And then genetic studies, which sidestep lifestyle entirely, landed in the same spot, which showed that drinking offered no heart protection.
And if you need more evidence, no major health body says to drink for your health, and that’s partly based on research that associated alcohol with at least seven cancers.
This doesn’t mean one drink will hurt you. But it does mean if you’re drinking consistently in the name of your health, you’ve been misled.
The Deep Dive
Hormone Therapy And Breast Cancer
Last week, we wrote about the misleading connection between hormone replacement therapy and dementia. And many of you wrote to ask whether HRT causes breast cancer. It’s a complicated answer, so we’ll provide a short overview and a deeper dive.
To be clear, you should discuss HRT with your physician. While physicians have differing viewpoints, this review summarizes what published research has found.
Does HRT raise breast cancer risk?
The short answer is that it depends on the type.
Estrogen paired with a progestogen (“combined” therapy) can raise breast cancer risk a little. Estrogen alone may not. And the FDA’s recent label change also deserves a bit more context.
For more than 20 years, hormone therapy carried a black-box warning, the FDA’s most serious label, and breast cancer was on it. A lot of women heard “hormones cause cancer” and never touched them.
Then, in November 2025, the FDA announced it would take breast cancer off that warning and started updating labels in February 2026. Plenty of people took that as an all-clear.
It wasn’t. Breast cancer is still listed in the label’s warnings, just not in the box. The truth is that the risk is low, but the type of therapy you use (and for how long, and at what age) determines just how much it increases your risk.
Combined therapy: If you still have your uterus, you need a progestogen with your estrogen to protect the uterine lining. That combination raises breast cancer risk modestly, and the risk climbs the longer you take it. Some of the extra risk can stick around for years after you stop, mostly after long-term use.
Estrogen alone: This is usually for women who’ve had a hysterectomy. Randomized trial data link it to lower breast cancer risk, though some observational studies find a small increase. Most scientists believe the data show little or no added risk.
If you’re healthy and starting near menopause, the added risk is small in absolute terms, especially with shorter use. And HRT is linked to real benefits for hot flashes and bone. The label got less scary, but the numbers didn’t change much. That’s a conversation to have with your doctor, with real numbers and no panic in either direction.
The Deep Dive
In 2002, a large US trial called the Women’s Health Initiative (WHI) was stopped early when women taking combined hormones had more breast cancers. Prescriptions collapsed, and HRT carried a black-box warning for over 20 years.
Last year the FDA moved to take breast cancer off that warning. Both moves were reactions to the same research, and both headlines left out what matters most: which hormones, for how long, and in whom.
In the WHI trial, more than 16,000 women with a uterus were randomly assigned to estrogen plus a synthetic progestin or to placebo. They took the pills for about five and a half years and were followed for over 20 years. Breast cancer was 28% more common on the hormones. In absolute terms, that’s about 9 extra cases per 10,000 women each year.
In the companion trial, nearly 11,000 women who’d had a hysterectomy took estrogen alone or placebo. Breast cancer was 22% less common on estrogen, and breast cancer deaths were lower too.
But as we pointed out above, an analysis of observational studies, covering more than 108,000 women with breast cancer, found a small increase with estrogen alone.
The randomized trial is the stronger design, but it tested one specific pill in women whose average age was 63. So “little or no increase” is the fair summary, and “protective” goes further than the evidence as a whole.
That analysis found risk with combined therapy climbed with years of use among current users, with it about 60% higher during the first four years and roughly double in years five through 14.
In practical terms, the data suggests five years of HRT starting at age 50 would mean, by age 69, about 1 extra breast cancer for every 50 women on daily combined therapy, 1 in 70 on intermittent combined therapy, and 1 in 200 on estrogen alone — if the link is causal.
However, in a French cohort of more than 80,000 women, estrogen combined with natural progesterone showed no increase in breast cancer, while estrogen with most synthetic progestins showed a 69% increase (and estrogen alone, a 29% increase). But it’s observational research, and the women (mostly teachers) differed from non-users in ways that could skew the results.
Just because the label changed doesn’t mean the recommendations have gone away.
The FDA recommended that treatment start before 60 or within 10 years of menopause. The Menopause Society reached a similar position in 2022: for women in that window, the benefits outweigh the risks for treating hot flashes and preventing bone loss in women at higher risk.
If you’re weighing HRT, you can start with three questions for your doctor: whether you need a progestogen (you do if you have a uterus), how long you’d take it, and what your own breast cancer risk looks like.
Better Today
Take any of these tips from today’s email and put them into action:
1. Teen Screen Time Limits, And Why Connection Matters More
Yes, too much screen time is associated with worse well-being. But counting screen hours can miss the real problem. Lonely kids scroll more. Kids who feel close to people do better. The key is fostering real connection. Find ways to include more quality time, whether it’s phone-free time each day or more deliberate conversations at dinner.
2. Is Red Wine Good for Your Heart? The Flawed Data
The apparent benefit of drinking wine came mostly from a flawed comparison: 86 of 107 cohort studies put former or occasional drinkers in the “abstainer” group, and the benefit disappeared once researchers corrected that. While the occasional glass of wine won’t do harm, daily drinking is not recommended, especially because alcohol consumption is linked to at least seven cancers, including breast, colorectal, liver, esophageal, and mouth and throat.
3. Does HRT Cause Breast Cancer?
The risk depends on the type, duration, and age of the person using it. Combined estrogen-plus-progestogen therapy modestly raises breast cancer risk, more with longer use (about 1 extra case per 50 women after 5 years of daily use from age 50), while estrogen alone shows little or no added risk. But HRT also has potential upside, so any type of hormone treatment should be discussed with your physician.
The Positive Corner of The Internet
About Arnold’s Pump Club Editorial Standards
We do things a bit differently here, starting with transparency.
The Content: All APC emails are researched, written, and fact-checked by the APC editors (see bottom of the email), with written contributions from Arnold (noted with “Arnold’s Corner”). Links take you to original studies (not second-hand sources).
Does AI play a role? Not for the primary content, but we use it in two ways. The main items are original content written by the APC team. The summaries at the end are AI-generated based on the human-written content above. We also use an AI tool to edit and review our interpretations of the research, ensuring scientific accuracy. We don’t assume AI is right, but we use technology to hold ourselves accountable.
Yes, we have partners (all clearly noted by “Together With”). Why? Because it allows us to keep the APC emails free. We first test products, and then reach out to potential partners who offer ways to help you improve every day. The bar is set high, and to date, we have turned down millions in ad deals. (Example: we will not partner with any non-certified supplements or those without evidence in human trials). If we won’t buy the product, we won’t recommend it to you. And if there’s no evidence it works, then there’s no place for it here.
—
Publisher: Arnold Schwarzenegger
Editors-in-chief: Adam Bornstein and Daniel Ketchell
